BOB (psychedelic)
Names | |
---|---|
IUPAC name
2-(4-bromo-2,5-dimethoxyphenyl)-2-methoxyethanamine | |
Other names
4-Bromo-2,5,β-trimethoxyphenethylamine 2-(4-Bromo-2,5,β-trimethoxyphenyl)ethanamine | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
PubChem CID |
|
| |
| |
Properties | |
C11H16BrNO3 | |
Molar mass | 290.1548 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
BOB, or 4-bromo-2,5,beta-trimethoxyphenethylamine, is a lesser-known psychedelic drug. It is the beta-methoxy analog of 2C-B. BOB was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 10–20 mg, and the duration listed as 10–20 hours. BOB produces an altered state of consciousness, tinnitus, a pleasant tingling throughout the body, and a sense of awareness.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOB.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
References
- ↑ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
See also
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.